Profits at U.S. hospital chains may come under stress from nursing shortage By Reuters

© Reuters. An emergency sign illuminates outside of George Washington University Hospital, one of roughly 400 Universal Health Services, Inc (UHS) facilities across the United States and the U.K., in Washington, D.C., September 29, 2020. REUTERS/Raphael Satter/File

By Manas Mishra

(Reuters) – A persistent shortage of nurses and related costs could pinch profits of U.S. hospital operators and take the shine off gains from increased hospitalization due to the Delta variant.

Wall Street analysts expect the largest publicly listed hospital operator, HCA Healthcare (NYSE:) Inc, to report a near doubling in quarterly earnings, but the profits could come under pressure from higher costs. The company is due to report earnings on Friday.

For HCA, “elevated nursing costs and labor pressures will remain in third-quarter 2021,” said Mizuho Securities analyst Ann Hynes in a research note.

Hospitals nationwide are finding it difficult to fill nursing jobs and have to pay more to recruit and retain nurses, a cost that they cannot afford in an era of tight margins.

“Because there is a shortage, people are willing to pay astronomical amounts to get the nursing staff that are so critical for taking care of patients,” said Tammy Lundstrom, chief medical officer at Trinity Health, a not-for-profit hospital system.

HCA Healthcare and smaller rival Tenet’s quarterly sales https://fingfx.thomsonreuters.com/gfx/mkt/mypmngqbkvr/nLM8w-hca-and-smaller-rival-tenet-s-quarterly-sales-so-far-.png

THE FUNDAMENTALS

** Nashville, Tennessee-based HCA is expected to report a 8.7% increase in revenue to $14.47 billion from $13.31 billion a year ago.

** The mean analyst estimate for Tenet’s earnings is $1.02 per share, while the mean analyst estimate for HCA’s earnings is $4 per share.

** HCA currently trades at 13.8x NTM P/E vs median of 12.9x NTM P/E for the wider health care provider sector.

WALL STREET SENTIMENT

** The current average analyst rating on HCA shares is “buy”

** Seven analysts rate HCA “strong buy”, 13 rate it “buy” and six rate it “hold”

** Wall Street’s median 12-month price target is $278.64

** HCA’s shares have risen over 80% in the past 12 months

Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures) and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn`t bear any responsibility for any trading losses you might incur as a result of using this data.

Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.

Be the first to comment

Leave a Reply

Your email address will not be published.


*